• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature.

作者信息

Jones M B, Osterholm R K, Wilson R B, Martin F H, Commers J R, Bachmayer J D

出版信息

Am J Med. 1978 Nov;65(5):855-63. doi: 10.1016/0002-9343(78)90806-9.

DOI:10.1016/0002-9343(78)90806-9
PMID:707543
Abstract

Mixed connective tissue disease (MCTD) has been characterized as a benign rheumatic syndrome with a favorable response to immunosuppressive therapy. Serious renal and pulmonary involvement are reported to be rare in MCTD. We are describing a female adolescent with MCTD in whom fatal cor pulmonale developed due to recurrent thromboembolic primary pulmonary hypertension. Death occurred after two years of therapy with prednisone and azathioprine for an immune-complex glomerulonephritis. Paramesangial and intramembranous electron-dense deposits had been identified in several glomeruli at the start of treatment. Improved renal function and apparent histologic improvement were demonstrated four months after the institution of prednisone and azathioprine therapy, and stable renal function was maintained until death. The pulmonary hypertension was progressive and apparently not altered by either the prednisone or azathioprine. At necropsy, there was no evidence of a pulmonary arteritis or vascular immune-complex deposition to account for the recurrent thromboembolic lesions in the small pulmonary arteries and arterioles. This is a clinical course not previously described in patients with MCTD and may represent an extreme of the clinical spectrum of this syndrome.

摘要

相似文献

1
Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease. A case report and review of the literature.
Am J Med. 1978 Nov;65(5):855-63. doi: 10.1016/0002-9343(78)90806-9.
2
Mixed connective tissue disease with fatal pulmonary hypertension.混合性结缔组织病伴致命性肺动脉高压。
Acta Pathol Jpn. 1982 Nov;32(6):1121-9. doi: 10.1111/j.1440-1827.1982.tb02093.x.
3
Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature.
Virchows Arch A Pathol Anat Histopathol. 1984;404(4):335-40. doi: 10.1007/BF00695217.
4
Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease.肺静脉闭塞性疾病作为混合性结缔组织病患者肺动脉高压的主要病因
Rheumatol Int. 2007 Oct;27(12):1163-5. doi: 10.1007/s00296-007-0362-1. Epub 2007 May 23.
5
Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.
J Rheumatol. 1987 Aug;14(4):826-30.
6
Glomerulonephritis in children with mixed connective tissue disease.
Clin Nephrol. 2006 Sep;66(3):160-5. doi: 10.5414/cnp66160.
7
Mesangial proliferative glomerulonephritis in mixed connective tissue disease (MCTD).
Clin Nephrol. 1980 Feb;13(2):93-6.
8
Pulmonary hypertension in a child with mixed connective tissue disease.
J Rheumatol. 1979 Nov-Dec;6(6):700-4.
9
A case of mixed connective tissue disease (MCTD) complicated with MPO-ANCA-related necrotizing glomerulonephritis.一例混合性结缔组织病(MCTD)合并MPO-ANCA相关性坏死性肾小球肾炎。
Clin Nephrol. 2000 Aug;54(2):164-8.
10
Massive pulmonary hemorrhage in mixed connective tissue diseases.混合性结缔组织病中的大量肺出血。
J Rheumatol. 1989 Aug;16(8):1132-4.

引用本文的文献

1
The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice.日常实践中抗核抗体(ANA)的解读技巧
J Clin Med. 2025 Jul 28;14(15):5322. doi: 10.3390/jcm14155322.
2
Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.混合性结缔组织病中的肺动脉高压:伊洛前列素治疗成功
Rheumatol Int. 2006 Jan;26(3):264-9. doi: 10.1007/s00296-005-0616-8. Epub 2005 Jul 12.
3
Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature.
Virchows Arch A Pathol Anat Histopathol. 1984;404(4):335-40. doi: 10.1007/BF00695217.
4
Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.抗核糖核蛋白抗体患者的临床特征
Clin Rheumatol. 1984 Dec;3(4):483-92. doi: 10.1007/BF02031271.
5
Cellular regulation of anti-nRNP antibody synthesis is different from that of anti-DNA antibody synthesis in patients with systemic lupus erythematosus.系统性红斑狼疮患者中,抗核糖核蛋白抗体合成的细胞调控与抗DNA抗体合成的细胞调控不同。
Rheumatol Int. 1988;8(4):177-83. doi: 10.1007/BF00270457.
6
Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.循环性狼疮抗凝物与混合性结缔组织病相关的肺动脉高压。
Clin Rheumatol. 1986 Jan;5(1):96-101. doi: 10.1007/BF02030976.
7
Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients.混合性结缔组织病是一种独特的疾病实体吗?混合性结缔组织病、系统性红斑狼疮、进行性系统性硬化症和类风湿关节炎患者的临床及实验室检查结果比较。
Clin Rheumatol. 1989 Mar;8(1):29-36. doi: 10.1007/BF02031065.
8
Pulmonary hypertension in connective tissue disease.结缔组织病中的肺动脉高压。
Clin Rheumatol. 1990 Mar;9(1):20-1. doi: 10.1007/BF02030235.
9
Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study.结缔组织病相关肺动脉高压。多机构研究中60例患者的临床分析。
Clin Rheumatol. 1990 Mar;9(1):56-62. doi: 10.1007/BF02030243.
10
Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody.
Clin Rheumatol. 1992 Jun;11(2):195-201. doi: 10.1007/BF02207956.